-
Johns Hopkins engineers have helped develop and characterize an artificial protein that triggers the same response in the human body as its natural counterpart—a breakthrough that not only has the… Read More
-
Breast cancer in its various forms affects more than 250,000 Americans a year. One particularly aggressive and hard-to-treat type is triple-negative breast cancer (TNBC), which lacks specific receptors targeted by… Read More
-
-
Two Johns Hopkins research teams have received technology development grants totaling approximately $200,000 through the Louis B. Thalheimer Fund for Translational Research. One of those teams includes researchers from the… Read More
-
While many only recognize mRNA as the crucial component in COVID-19 vaccines that have helped protect more than 230 million people around the world from contracting or developing severe disease… Read More
-
Skin is the body’s most visible organ. But have we ever really seen it? “No one has viewed the skin in three dimensions at single-cell resolution,” said Denis Wirtz, professor in… Read More
